【摘 要】
：
The aim of this study was to evaluate the clinical activity of another angiogenesis inhibitor Endostar (rh-endostatin) in combination with continued EGFR-TKIs (including erlotinib,gefitinib and icotin
【机 构】
：
Shanxi Cancer Hospital China
论文部分内容阅读
The aim of this study was to evaluate the clinical activity of another angiogenesis inhibitor Endostar (rh-endostatin) in combination with continued EGFR-TKIs (including erlotinib,gefitinib and icotinib) for advanced NSCLC patients who had developed acquired resistance to prior EGFR-TKIs treatment.
其他文献
The functional role of stromal cells in the tumor microenvironment (TME) in modifying tumor sensitivity is increasingly recognized as a key factor for the development of advanced anticancer therapeuti
Photodynamic therapy (PDT) is regarded as a treatment option for basal cell carcinoma (BCC).The aim of this study is to investigate the efficacy of methylene blue (MB)-based PDT in patients suffering
In our original attempts to reshape anticancer arsenals from traumatic surgery,through minimally invasive interventions into noninvasive targeted strategy,we have developed a broad-spectrum chemoradio
As growing promise in engineered immune cells for cancer therapy,for example,Chimeric Antigen Receptors T cells (CAR-T) can recognize and eliminate tumor cells expressing specific antigens,optimal man
Gastric cancer is the third leading cause of cancer related death worldwide,and some of the highest mortality rates are in East Asia.Targeted cancer therapies provide new hope to patients with gastric
Melanoma is one of the most aggressive malignant diseases in human,and the best treatment outcome could be achieved when the diseases is diagnosed at the earlier stages.
In recent years,major advances have been made in interventional.Notable techniques have been developed and actually cryosurgery has positioned in an important place in solution of lung and trachea-bro
Non-small cell lung cancer (NSCLC) is the predominant type of lung cancer,the most common malignancy in the world.Although lung carcinogenesis is an extensively studied disorder,it still requires clar
Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth factor receptor (EGFR) have shown promising clinical efficacy in non-squamous non-small cell lung cancer (NSCLC);however,resistance is
Lung Cancer is the most frequent cancer worldwide with more than 1,3 M new case each year.The years 2000 saw two major changes in lung cancer,the predominance of adenocarcinoma and a personalized trea